Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Autolus Therapeutics plc ADR (NASDAQ: AUTL) closed at $2.49 down -7.43% from its previous closing price of $2.69. In other words, the price has decreased by -$7.43 from its previous closing price. On the day, 4.14 million shares were traded. AUTL stock price reached its highest trading level at $2.72 during the session, while it also had its lowest trading level at $2.45.
Ratios:
For a deeper understanding of Autolus Therapeutics plc ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.64 and its Current Ratio is at 13.64. In the meantime, Its Debt-to-Equity ratio is 0.63 whereas as Long-Term Debt/Eq ratio is at 0.62.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on November 18, 2024, Upgraded its rating to Buy and sets its target price to $7.60 from $7 previously.
On November 15, 2024, Redburn Atlantic Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $13.
On November 09, 2023, Deutsche Bank started tracking the stock assigning a Buy rating and target price of $10.Deutsche Bank initiated its Buy rating on November 09, 2023, with a $10 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 16 ’24 when Martin Pule bought 698,741 shares for $4.23 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AUTL now has a Market Capitalization of 662643776 and an Enterprise Value of 306655616. For the stock, the TTM Price-to-Sale (P/S) ratio is 65.67 while its Price-to-Book (P/B) ratio in mrq is 1.39. Its current Enterprise Value per Revenue stands at 30.389 whereas that against EBITDA is -1.49.
Stock Price History:
Over the past 52 weeks, AUTL has reached a high of $7.45, while it has fallen to a 52-week low of $2.69. The 50-Day Moving Average of the stock is -30.62%, while the 200-Day Moving Average is calculated to be -40.50%.
Shares Statistics:
For the past three months, AUTL has traded an average of 1.59M shares per day and 1820070 over the past ten days. A total of 266.12M shares are outstanding, with a floating share count of 236.67M. Insiders hold about 11.06% of the company’s shares, while institutions hold 56.29% stake in the company. Shares short for AUTL as of 1732838400 were 6293312 with a Short Ratio of 3.96, compared to 1730332800 on 7193936. Therefore, it implies a Short% of Shares Outstanding of 6293312 and a Short% of Float of 3.19.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 5.0 analysts currently analyzing and rating the stock of Autolus Therapeutics plc ADR (AUTL).The consensus estimate for the next quarter is -$0.22, with high estimates of -$0.21 and low estimates of -$0.24.
Analysts are recommending an EPS of between -$0.68 and -$1.09 for the fiscal current year, implying an average EPS of -$0.92. EPS for the following year is -$0.8, with 7.0 analysts recommending between -$0.64 and -$0.93.
Revenue Estimates
For the next quarter, 6 analysts are estimating revenue of $17.52M. There is a high estimate of $17.52M for the next quarter, whereas the lowest estimate is $17.52M.
A total of 8 analysts have provided revenue estimates for AUTL’s current fiscal year. The highest revenue estimate was $50M, while the lowest revenue estimate was $10.09M, resulting in an average revenue estimate of $17.33M. In the same quarter a year ago, actual revenue was $1.7MBased on 8 analysts’ estimates, the company’s revenue will be $57.9M in the next fiscal year. The high estimate is $119.15M and the low estimate is $18.34M.
